Table 5. Adverse events of therapy.
SOF+Peg-IFN+RBV (n = 70) | SOF+LDV (n = 52) | SOF+LDV+RBV (n = 63) | Total (N = 185) | |
---|---|---|---|---|
Fatigue | 17 (24.3) | 4 (7.7) | 6 (9.5) | 27 (14.6) |
Anemia | 9 (12.9) | 0 (0.0) | 5 (7.9) | 14 (7.6) |
Headache | 6 (8.6) | 3 (5.8) | 4 (6.3) | 13 (7.0) |
Flu-like symptoms | 12 (17.1) | 0 (0.0) | 0 (0.0) | 12 (6.5) |
Nausea | 7 (10.0) | 1 (1.9) | 2 (3.2) | 10 (5.4) |
Neutropenia | 6 (8.6) | 0 (0.0) | 0 (0.0) | 6 (3.2) |
SOF: Sofosbuvir; Peg-IFN: Pegylated interferon; RBV: Ribavirin; LDV: ledipasvir.